Artivion (AORT) Competitors $28.40 -0.77 (-2.64%) As of 09:46 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AORT vs. NARI, INSP, IRTC, BLCO, TMDX, SLNO, NVST, PRCT, LIVN, and ENOVShould you be buying Artivion stock or one of its competitors? The main competitors of Artivion include Inari Medical (NARI), Inspire Medical Systems (INSP), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. Artivion vs. Inari Medical Inspire Medical Systems iRhythm Technologies Bausch + Lomb TransMedics Group Soleno Therapeutics Envista PROCEPT BioRobotics LivaNova Enovis Artivion (NYSE:AORT) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, community ranking, earnings, analyst recommendations and dividends. Do insiders and institutionals hold more shares of AORT or NARI? 86.4% of Artivion shares are held by institutional investors. Comparatively, 91.0% of Inari Medical shares are held by institutional investors. 7.6% of Artivion shares are held by insiders. Comparatively, 10.6% of Inari Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media refer more to AORT or NARI? In the previous week, Artivion had 5 more articles in the media than Inari Medical. MarketBeat recorded 5 mentions for Artivion and 0 mentions for Inari Medical. Artivion's average media sentiment score of 0.99 beat Inari Medical's score of 0.84 indicating that Artivion is being referred to more favorably in the media. Company Overall Sentiment Artivion Positive Inari Medical Positive Is AORT or NARI more profitable? Artivion has a net margin of -0.22% compared to Inari Medical's net margin of -13.68%. Artivion's return on equity of 5.15% beat Inari Medical's return on equity.Company Net Margins Return on Equity Return on Assets Artivion-0.22% 5.15% 1.91% Inari Medical -13.68%-10.09%-6.60% Which has stronger valuation & earnings, AORT or NARI? Inari Medical has higher revenue and earnings than Artivion. Inari Medical is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArtivion$390.08M3.12-$30.69M-$0.50-57.09Inari Medical$493.63M9.48-$1.64M-$1.35-59.24 Does the MarketBeat Community believe in AORT or NARI? Inari Medical received 36 more outperform votes than Artivion when rated by MarketBeat users. However, 83.33% of users gave Artivion an outperform vote while only 57.89% of users gave Inari Medical an outperform vote. CompanyUnderperformOutperformArtivionOutperform Votes3083.33% Underperform Votes616.67%Inari MedicalOutperform Votes6657.89% Underperform Votes4842.11% Which has more risk & volatility, AORT or NARI? Artivion has a beta of 1.54, meaning that its share price is 54% more volatile than the S&P 500. Comparatively, Inari Medical has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Do analysts rate AORT or NARI? Artivion presently has a consensus target price of $31.40, suggesting a potential upside of 10.00%. Inari Medical has a consensus target price of $69.22, suggesting a potential downside of 13.44%. Given Artivion's stronger consensus rating and higher possible upside, research analysts clearly believe Artivion is more favorable than Inari Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Artivion 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17Inari Medical 0 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14 SummaryArtivion beats Inari Medical on 12 of the 19 factors compared between the two stocks. Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AORT vs. The Competition Export to ExcelMetricArtivionSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$1.22B$4.47B$5.35B$19.38BDividend YieldN/A43.64%5.22%3.83%P/E Ratio-1,427.2529.4326.8434.23Price / Sales3.1267.72392.3434.85Price / Cash36.7851.0838.2517.51Price / Book4.166.236.794.69Net Income-$30.69M$68.16M$3.23B$1.02B7 Day Performance-1.30%18.33%4.07%-1.34%1 Month Performance26.31%23.04%12.52%9.79%1 Year Performance21.68%20.61%16.83%3.27% Artivion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AORTArtivion2.3363 of 5 stars$28.40-2.6%$31.40+10.6%+21.7%$1.21B$390.08M-1,415.801,300Insider TradeNARIInari Medical0.5703 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.675 of 5 stars$156.54+3.5%$211.91+35.4%-4.0%$4.62B$840.11M90.49760Positive NewsGap UpIRTCiRhythm Technologies1.2775 of 5 stars$137.80+0.1%$128.55-6.7%+52.9%$4.40B$618.59M-37.861,790Positive NewsBLCOBausch + Lomb4.1449 of 5 stars$11.91+5.6%$15.50+30.2%-22.8%$4.21B$4.83B-13.0812,500Gap UpTMDXTransMedics Group1.3197 of 5 stars$118.73+6.5%$126.70+6.7%-12.4%$4.02B$488.23M126.31210Positive NewsSLNOSoleno Therapeutics4.8537 of 5 stars$76.70-0.1%$106.78+39.2%+65.6%$3.87BN/A-23.1030News CoveragePositive NewsNVSTEnvista4.1823 of 5 stars$18.56+5.5%$20.08+8.2%-9.2%$3.15B$2.50B-2.8612,700Positive NewsGap DownPRCTPROCEPT BioRobotics2.923 of 5 stars$54.44+2.5%$90.00+65.3%-17.6%$3.01B$249.12M-27.92430Positive NewsLIVNLivaNova3.7951 of 5 stars$45.23+2.7%$59.17+30.8%-27.9%$2.47B$1.28B107.692,900Positive NewsAnalyst UpgradeHigh Trading VolumeENOVEnovis3.1922 of 5 stars$36.67+11.0%$55.00+50.0%-35.7%$2.09B$2.15B-16.746,800Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Inari Medical Competitors Inspire Medical Systems Competitors iRhythm Technologies Competitors Bausch + Lomb Competitors TransMedics Group Competitors Soleno Therapeutics Competitors Envista Competitors PROCEPT BioRobotics Competitors LivaNova Competitors Enovis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AORT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artivion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artivion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AORT Stock Free AORT Stock Alerts